BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,195 | -21.1% | 16,113 | -0.7% | 0.02% | -15.0% |
| Q2 2023 | $1,025,104 | +37.1% | 16,220 | -2.4% | 0.02% | +42.9% |
| Q1 2023 | $747,824 | -57.0% | 16,622 | +2.4% | 0.01% | -36.4% |
| Q4 2021 | $1,739,000 | -38.0% | 16,225 | -40.5% | 0.02% | -40.5% |
| Q3 2021 | $2,805,000 | +121.0% | 27,278 | +89.2% | 0.04% | +164.3% |
| Q2 2021 | $1,269,000 | +182.6% | 14,418 | +212.7% | 0.01% | +180.0% |
| Q1 2021 | $449,000 | +14.0% | 4,611 | +31.5% | 0.01% | +25.0% |
| Q4 2020 | $394,000 | -53.3% | 3,507 | -61.5% | 0.00% | -60.0% |
| Q3 2020 | $844,000 | +2.9% | 9,103 | -13.3% | 0.01% | 0.0% |
| Q2 2020 | $820,000 | – | 10,503 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |